• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Therini Bio Begins Ph 1b Trial of THN391 in Alzheimer’s Disease

    GLOBENEWSWIRE

    Therini Bio Raises $39M to Advance Neurodegenerative Pipeline

    GLOBENEWSWIRE

    Therini Bio reports positive Phase 1a trial results for THN391

    GLOBENEWSWIRE

    Therini Positive Preclinical Data For THN391 In Ocular Diseases

    GLOBENEWSWIRE

    Therini Bio Announces Interim Results from the Phase 1 Trial of THN391

    GLOBENEWSWIRE

    Therini Bio Initiates First-In-Human Dosing in Ph 1 Trial of THN391

    BUSINESSWIRE

    Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.